Alleviation of prilocaine-induced epileptiform activity and cardiotoxicity by thymoquinone
- 19 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in DARU Journal of Pharmaceutical Sciences
- Vol. 29 (1), 85-99
- https://doi.org/10.1007/s40199-020-00385-2
Abstract
Purpose This study investigated whether thymoquinone (TQ) could alleviate central nervous system (CNS) and cardiovascular toxicity of prilocaine, a commonly used local anesthetic. Methods Rats were randomized to the following groups: control, prilocaine treated, TQ treated and prilocaine + TQ treated. Electroencephalography and electrocardiography electrodes were placed and trachea was intubated. Mechanical ventilation was initiated, right femoral artery was cannulated for continuous blood pressure measurements and blood-gas sampling while the left femoral vein was cannulated for prilocaine infusion. Markers of myocardial injury, reactive oxygen/nitrogen species (ROS/RNS) generation and total antioxidant capacity (TAC) were assayed by standard kits. Aquaporin-4 (AQP4), nuclear factor(NF)κB-p65 and -p50 subunit in brain tissue were evaluated by histological scoring. Results Blood pH and partial oxygen pressure, was significantly decreased after prilocaine infusion. The decrease in blood pH was alleviated in the prilocaine + TQ treated group. Prilocaine produced seizure activity, cardiac arrhythmia and asystole at significantly lower doses compared to prilocaine + TQ treated rats. Thymoquinone administration attenuated levels of myocardial injury induced by prilocaine. Prilocaine treatment caused increased ROS/RNS formation and decreased TAC in heart and brain tissue. Thymoquinone increased heart and brain TAC and decreased ROS/RNS formation in prilocaine treated rats. AQP4, NFκB-p65 and NFκB-p50 expressions were increased in cerebellum, cerebral cortex, choroid plexus and thalamic nucleus in prilocaine treated rats. Thymoquinone, decreased the expression of AQP4, NFκB-p65 and NFκB-p50 in brain tissue in prilocaine + TQ treated rats. Conclusion Results indicate that TQ could ameliorate prilocaine-induced CNS and cardiovascular toxicity. Graphical abstractFunding Information
- Akdeniz Üniversitesi (TTU-2017-2551)
This publication has 54 references indexed in Scilit:
- ASRA Practice Advisory on Local Anesthetic Systemic ToxicityRegional Anesthesia & Pain Medicine, 2010
- Cardioprotective Effects of Nigella sativa Oil on Cyclosporine A‐Induced Cardiotoxicity in RatsBasic & Clinical Pharmacology & Toxicology, 2008
- The role of cytokines in the pathophysiology of epilepsyBrain, Behavior, and Immunity, 2008
- Involvement of aquaporin-4 in astroglial cell migration and glial scar formationJournal of Cell Science, 2005
- Antiepileptogenic and antioxidant effects of Nigella sativa oil against pentylenetetrazol-induced kindling in miceNeuropharmacology, 2005
- Major Complications of Regional Anesthesia in FranceAnesthesiology, 2002
- Aquaporins in Brain: Distribution, Physiology, and PathophysiologyJournal of Cerebral Blood Flow & Metabolism, 2002
- Adverse Effects and Drug Interactions Associated with Local and Regional AnaesthesiaDrug Safety, 1998
- Comparison of acute central nervous system and cardiovascular toxicity of 2‐chloroprocaine and prilocaine in the ratActa Anaesthesiologica Scandinavica, 1993
- Influence of Enzyme Induger on Methaemoglobinaemia Caused by PrilocaineActa Anaesthesiologica Scandinavica, 1968